Health News
GlaxoSmithKline seeks U.S. approval for triple lung drug
LONDON GlaxoSmithKline said on Monday it had filed its new three-in-one inhaled lung drug for U.S. approval, putting it on track to reach the market ahead of rivals in 2017, assuming it wins a green light.
More Headlines
Parents of children with cancer see income dips and loss of employment
(Reuters Health) – - Even accounting for social and economic status, having a child with cancer is tied to income reductions for parents and job discontinuation for mothers, according to a new study.
Iran reports outbreaks of H5N8 bird flu in Tehran area: OIE
PARIS Iran reported two outbreaks of the highly contagious H5N8 bird flu virus at farms located in the Tehran region, the World Organisation for Animal Health (OIE) said on Monday, citing a report from the Iranian agriculture ministry.
More than 18 million on HIV treatment, a million more than 2015: UNAIDS
LONDON, Nov 21 - More than 18 million people now have access to life-saving AIDS treatment, 1.2 million more than at the end of last year, the United Nations said on Monday.
Thanksgiving when teens don’t eat like the rest of the family
(Reuters Health) - Some families gathering for Thanksgiving this week may have something to argue about besides politics: what to do when teens at the table follow a different diet than everyone else.
Health Watch Graphics
Track and Field - Injuries overview
Based on injury events from 2002-2015 that involved a trip to an emergency room in the United States. Full Article
Sleep apnea by the numbers
Sleep apnea is thought to affect at least 5 percent of men and 3-4 percent of women, but many estimates put that number higher because people with sleep apnea don't tend to realize they have it. Interactive